UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2017-01, Vol.317 (4), p.379

2017

Volltextzugriff (PDF)

Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls

Diabetologia, 2021-07, Vol.64 (7), p.1595-1603

2021

Volltextzugriff (PDF)

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin

Diabetes, obesity & metabolism, 2014-02, Vol.16 (2), p.159-169

2014

Volltextzugriff (PDF)

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

Diabetologia, 2012-12, Vol.55 (12), p.3155-3162

2012

Volltextzugriff (PDF)

OP4 SWITCH : Optimisation du contrôle métabolique avec une éducation thérapeutique intensive

Diabetes & metabolism, 2013-03, Vol.39, p.A122-A122

2013

Volltextzugriff (PDF)

P1020 Efficacité de la mesure du glucose en continu couplée à la pompe à insuline chez des patients diabétiques de type 1 ayant un contrôle métabolique sous-optimal. L’étude SWITCH

Diabetes & metabolism, 2013-03, Vol.39, p.A37-A37

2013

Volltextzugriff (PDF)

Simultaneous velocity and concentration measurements in the near field of a turbulent low-pressure jet by digital particle image velocimetry-planar laser-induced fluorescence

Experiments in fluids, 2001-08, Vol.31 (2), p.140-152

2001

Volltextzugriff (PDF)

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Diabetes care, 2021-01, Vol.44 (1), p.141-149

2021

Volltextzugriff (PDF)

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

Diabetes technology & therapeutics, 2018-04, Vol.20 (4), p.274-284

2018

Volltextzugriff (PDF)

Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin

Diabetes, obesity & metabolism, 2012-11, Vol.14 (11), p.990-999

2012

Volltextzugriff (PDF)

CLOuDs Disperse — Top-Notch Glucose Control and Residual C-Peptide Secretion

The New England journal of medicine, 2022-09, Vol.387 (10), p.937-938

Bolinder, Jan

2022

Volltextzugriff (PDF)

Could FreeStyle Libre™ sensor glucose data support decisions for safe driving?

Diabetic medicine, 2018-04, Vol.35 (4), p.491-494

2018

Volltextzugriff (PDF)

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)

Diabetes, obesity & metabolism, 2021-02, Vol.23 (2), p.619-630

2021

Volltextzugriff (PDF)

Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study

Acta diabetologica, 2014-10, Vol.51 (5), p.845-851

2014

Volltextzugriff (PDF)

Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial

Journal of diabetes science and technology, 2023, Vol.In Press, p.19322968231183974-19322968231183974

2023

Volltextzugriff (PDF)

Fear of hypoglycaemia in adults with Type 1 diabetes

Diabetic medicine, 2010-10, Vol.27 (10), p.1151-1158

2010

Volltextzugriff (PDF)

Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

Diabetes therapy, 2023-09, Vol.14 (9), p.1563-1575

2023

Volltextzugriff (PDF)

Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983–2002

Journal of internal medicine, 2008, Vol.263 (4), p.386-394

2008

Volltextzugriff (PDF)

Adipose zinc-a2-glycoprotein is a catabolic marker in cancer and noncancerous states

Journal of internal medicine, 2012-04, Vol.271 (4), p.414

2012

Volltextzugriff (PDF)

Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects : results from the nationwide Diabetes Incidence Study in Sweden (DISS)

Diabetologia, 2006, Vol.49 (12), p.2847-2852

2006

Volltextzugriff (PDF)

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

The Lancet (British edition), 2016-11, Vol.388 (10057), p.2254-2263

2016

Volltextzugriff (PDF)

Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults

Diabetic medicine, 2011-02, Vol.28 (2), p.156-161

2011

Volltextzugriff (PDF)

Overweight, hyperglycemia and tobacco use are modifiable risk factors for onset of retinopathy 9 and 17 years after the diagnosis of diabetes – A retrospective observational nation-wide cohort study

Diabetes research and clinical practice, 2017, Vol.133, p.21-29

2017

Volltextzugriff (PDF)

Adipose zinc-α2-glycoprotein is a catabolic marker in cancer and noncancerous states

Journal of internal medicine, 2012-04, Vol.271 (4), p.414-420

2012

Volltextzugriff (PDF)

New insulins and insulin therapy

International journal of clinical practice (Esher), 2011-02, Vol.65 (s170), p.26-30

2011

Volltextzugriff (PDF)

1 – 25 von 339

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(329)
Mit Volltextzugriff
(251)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(206)
Humans
(201)
Life Sciences & Biomedicine
(199)
Medicin Och Hälsovetenskap
(162)
Adult
(145)
Biological And Medical Sciences
(134)
Male
(128)
Female
(126)
Endocrinology & Metabolism
(106)
Medical Sciences
(105)
Middle Aged
(82)
Endocrinopathies
(54)
Diabetes
(52)
Adipose Tissue - Metabolism
(48)
Endocrine Pancreas. Apud Cells
(46)
Diabetes. Impaired Glucose Tolerance
(45)
Insulin
(45)
Clinical Medicine
(41)
Blood Glucose - Metabolism
(38)
Fundamental And Applied Biological Sciences. Psychology
(38)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial

Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

OP4 SWITCH : Optimisation du contrôle métabolique avec une éducation thérapeutique intensive

P1020 Efficacité de la mesure du glucose en continu couplée à la pompe à insuline chez des patients diabétiques de type 1 ayant un contrôle métabolique sous-optimal. L’étude SWITCH

Simultaneous velocity and concentration measurements in the near field of a turbulent low-pressure jet by digital particle image velocimetry-planar laser-induced fluorescence

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin

CLOuDs Disperse — Top-Notch Glucose Control and Residual C-Peptide Secretion

Could FreeStyle Libre™ sensor glucose data support decisions for safe driving?

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)

Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study

Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial

Fear of hypoglycaemia in adults with Type 1 diabetes

Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983–2002

Adipose zinc-a2-glycoprotein is a catabolic marker in cancer and noncancerous states

Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects : results from the nationwide Diabetes Incidence Study in Sweden (DISS)

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults

Overweight, hyperglycemia and tobacco use are modifiable risk factors for onset of retinopathy 9 and 17 years after the diagnosis of diabetes – A retrospective observational nation-wide cohort study

Adipose zinc-α2-glycoprotein is a catabolic marker in cancer and noncancerous states

New insulins and insulin therapy

Suchergebnisse filtern